Caplin Point Laboratories Ltd Q1 FY27 Share Price & Earnings Call Analysis

Financials of Caplin Point Laboratories Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Caplin Point Laboratories Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +389395410436453459483493502510534543600
Expenses +265269273293308307318331334332345353396
Operating Profit124127137142145152165162168178189190204
OPM %32%32%34%33%32%33%34%33%33%35%35%35%34%
Other Income +11122117171921312623303428
Interest0000000000000
Depreciation11111214161617161716181919
Profit before tax124127146145146154168177177184201204213
Tax %18%18%20%18%17%19%22%21%18%18%20%19%19%
Net Profit +101104116120121125131140145151160166173
EPS in Rs13.4513.6215.1315.4316.0116.3117.2118.2818.7620.1020.3221.5622.38

Financials of Caplin Point Laboratories Ltd

Profit & Loss

Annual income statement trend

Jun 2015Mar 2016 9mMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +2522394025406498631,0611,2691,4671,6941,9372,187
Expenses +1921752763454176037328741,0251,1421,2871,426
Operating Profit6064125195232260329395442552651761
OPM %24%27%31%36%36%30%31%31%30%33%34%35%
Other Income +34101319412338556692116
Interest101110211111
Depreciation8713192332374745536673
Profit before tax5360121188227269314386451564677803
Tax %23%24%21%23%22%20%20%20%16%18%20%19%
Net Profit +414696145177215251308377461541650
EPS in Rs5.436.0512.6519.1523.3528.4232.0339.5649.5760.1970.5684.36
Dividend Payout %18%20%12%10%9%9%9%10%9%8%8%5%

Financials of Caplin Point Laboratories Ltd

Balance Sheet

Capital structure and asset base

Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital151515151515151515151515
Reserves781132103495828589541,2521,6492,0842,6193,571
Borrowings +2211361132352192222192225
Other Liabilities +134137133136109139159250305380352454
Total Liabilities2292673585007431,1261,3641,7362,1912,6983,2084,045
Fixed Assets +113144152169227272305287280453546605
CWIP31031510201418221117144209
Investments00174770611189281376590859
Other Assets +851221862694367721,0331,3431,4101,7531,9282,373
Total Assets2292673585007431,1261,3641,7362,1912,6983,2084,045

Financials of Caplin Point Laboratories Ltd

Cash Flows

Operating, investing and financing cash movement

Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +504268668345269337271318432523
Cash from Investing Activity +-23-6-36-69-100-54-30-377-216-319-333-582
Cash from Financing Activity +-9-14-7-129080-24-41-28-38-38-46
Net Cash Flow192325-147370215-8127-3961-106
Free Cash Flow2434431818-3219524678173241275
CFO/OP103%92%73%53%54%38%102%106%81%77%86%88%

Financials of Caplin Point Laboratories Ltd

Ratios

Working capital efficiency and return ratios

Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days81230859097969198117119138
Inventory Days3757444447210139149159183159181
Days Payable11216815514476576810284116103125
Cash Conversion Cycle-67-99-81-1661251166138173184175194
Working Capital Days-128-114-2947104167145165144166174263
ROCE %68%62%68%63%45%33%28%28%26%26%26%25%